| Real Estate Management & Development Industry | Real Estate Sector | Zhaoting Lu CEO | TWSE Exchange | TW0001436004 ISIN |
| TW Country | - Employees | 25 Jul 2023 Last Dividend | 3 Sep 2018 Last Split | - IPO Date |
SciVision Biotech Inc., established in 1990 and headquartered in Kaohsiung, Taiwan, operates on a global scale, specializing in the development, production, and distribution of hyaluronic acid-based medical products. This company has carved out a niche in the biomedical sector with its diverse range of products that serve a variety of medical needs, including cosmetic enhancements and therapeutic treatments. In addition to its product offerings, SciVision Biotech Inc. extends its expertise to the wholesale of medical equipment and also delivers management consulting services, highlighting its versatility and dedication to advancing healthcare solutions.
In addition to these specialized products, SciVision Biotech Inc. engages in the wholesale of medical equipment, providing an array of tools and devices crucial for healthcare facilities. The company also leverages its industry insight to offer management consulting services, aiding other organizations in navigating the complex healthcare market effectively.